Aspirin for Preventing the Recurrence of Venous Thromboembolism
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: About 20% of patients with unprovoked venous thromboembolism have a recurrence within 2 years after the withdrawal of oral anticoagulant therapy. Extending anticoagulation prevents recurrences but is associated with increased bleeding. The benefit of aspirin for the prevention of recurrent venous thromboembolism is unknown. METHODS: In this multicenter, investigator-initiated, double-blind study, patients with first-ever unprovoked venous thromboembolism who had completed 6 to 18 months of oral anticoagulant treatment were randomly assigned to aspirin, 100 mg daily, or placebo for 2 years, with the option of extending the study treatment. The primary efficacy outcome was recurrence of venous thromboembolism, and major bleeding was the primary safety outcome. RESULTS: Venous thromboembolism recurred in 28 of the 205 patients who received aspirin and in 43 of the 197 patients who received placebo (6.6% vs. 11.2% per year; hazard ratio, 0.58; 95% confidence interval [CI], 0.36 to 0.93) (median study period, 24.6 months). During a median treatment period of 23.9 months, 23 patients taking aspirin and 39 taking placebo had a recurrence (5.9% vs. 11.0% per year; hazard ratio, 0.55; 95% CI, 0.33 to 0.92). One patient in each treatment group had a major bleeding episode. Adverse events were similar in the two groups. CONCLUSIONS: Aspirin reduced the risk of recurrence when given to patients with unprovoked venous thromboembolism who had discontinued anticoagulant treatment, with no apparent increase in the risk of major bleeding. (Funded by the University of Perugia and others; WARFASA ClinicalTrials.gov number, NCT00222677.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The WARFASA 309 and ASPIRE 318 trials compared aspirin, 100 mg daily, with placebo for secondary prevention of recurrent VTE for patients with an initial unprovoked event, and the pooled results of the 2 trials showed a decrease in recurrent VTE, as well as major vascular events, without an increased risk for clinically relevant bleeding. 309,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [309]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Consequently, several studies have investigated the role of aspirin for the secondary prevention of VTE. 309,314,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [309]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007903 · Cited by 3,237
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
Prandoni, P., Lensing, A. W. A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A. M., Polistena, P., Bernardi, E., & Prins, M. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00001 · Cited by 2,109
Self-citationAntithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Self-citationAntithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Self-citation(2000) · The Lancet · doi:10.1016/s0140-6736(00)02110-3 · Cited by 1,076
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
del Conde, I., Shrimpton, C. N., Thiagarajan, P., & López, J. A. (2005) · Blood · doi:10.1182/blood-2004-03-1095 · Cited by 1,029
Schulman, S., Rhedin, A.-S., Lindmarker, P., Carlsson, A., Lärfars, G., Nicol, P., Loogna, E., Svensson, E., Ljungberg, B., Walter, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322501 · Cited by 932
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
Ridker, P. M., Goldhaber, S. Z., Danielson, E., Rosenberg, Y., Eby, C. S., Deitcher, S. R., Cushman, M., Moll, S., Kessler, C. M., Elliott, C. G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035029 · Cited by 808
Linkins, L.-A., Choi, P. T., & Douketis, J. D. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00007 · Cited by 764
Research works printed but not linked: 2
- Schulman S, 2011, J Thromb Haemost, 9, 731
- Schulman S, 2011, J Thromb Haemost, 9, 22
Cited by
Items 501–600 of 630
Deep Vein Thrombosis and Pulmonary Embolus Thrombolysis and Endovascular Treatment
Muck, P. E. (2021) · Springer eBooks · doi:10.1007/978-1-0716-1089-3_33 · Cited by 1
Venous Thromboembolism for the Practicing Cardiologist
Pribish, A. M., Secemsky, E. A., & Schmaier, A. A. (2021) · Cardiology Clinics · doi:10.1016/j.ccl.2021.06.008 · Cited by 1
The Year in Interventional Cardiology
Dixon, S. R., & Safian, R. D. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.040 · Cited by 2
Role of Follow-Up Duplex Ultrasound Post-Deep Vein Thrombosis
Broering, M. J., & Muck, P. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-60626-8_67 · Cited by 1
Bauersachs, R. M., Kröger, M., Schrör, K., Hohlfeld, T., Spannagl, M., & Hart, C. (2014) · Springer eBooks · doi:10.1007/978-3-642-21496-7_5 · Cited by 1
Özbeyaz, N. B., Açıkel, S., Algül, E., Şahan, H. F., Aydınyılmaz, F., Felekoğlu, M. A., Gökalp, G., & Gulıyev, İ. (2022) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1110150 · Cited by 1
Therapeutic Drug Monitoring (TDM) in The Use of Aspirin as Antirheumatoid Drugs
Miladiyah, I. (2012) · Sains Medika Jurnal Kedokteran dan Kesehatan · doi:10.30659/sainsmed.v4i2.378 · Cited by 7
Duration of anticoagulation of venous thromboembolism
Couturaud, F., Meneveau, N. F., Sevestre, M., Morange, P., & Jiménez, D. (2024) · La Presse Médicale · doi:10.1016/j.lpm.2024.104245 · Cited by 1
del Pozo, M. M., Asenjo, M. M., Franco‐Moreno, A., de Antonio, E. U., & Valle, F. G. (2024) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2024.10.004 · Cited by 1
Glycemic control in youth with type 2 diabetes.
Krishnan, N., & Krishnan, R. (2012) · PubMed · doi:10.1056/nejmc1208408 · Cited by 1
Aspirin for prophylaxis of venous thromboembolism
Ting, C., de Carvalho, L. P., & Chan, M. Y. (2014) · ASEAN heart journal · doi:10.7603/s40602-014-0009-x · Cited by 1
The American Venous Forum: Leveraging our strengths
Henke, P. K. (2014) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2014.04.002 · Cited by 1
Bauersachs, R. M., & Krabbe, B. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_208 · Cited by 1
Antikoagulation nach Venenthrombosen und Pulmonalembolien
Eichinger, S. (2013) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Self-citationAspirin for Prevention of Thromboembolism Recurrence
Edwards, C., & Taylor, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1207382
Long-Term Management of Venous Thromboembolism: Strategies for Reducing the Risk of Recurrence
Piazza, G., Hohlfelder, B., & Goldhaber, S. Z. (2015) · Springer eBooks · doi:10.1007/978-3-319-20843-5_10
Aktuelle Therapie und Sekundärprävention der Lungenembolie
Lankeit, M., & Konstantinides, S. (2013) · Der Kardiologe · doi:10.1007/s12181-013-0481-8
Hayek, S., & Batura, D. (2015) · International Urology and Nephrology · doi:10.1007/s11255-015-1122-x
Faible dose d'aspirine en prévention secondaire des thromboembolies veineuses : étude ASPIRE
Spinewine, A., & Larock, A. (2013) · Pharmactuel
Chapitre 31 – Thérapeutique de la thrombose veineuse profonde
Élias, A., & Pernod, G. (2015) · doi:10.1016/b978-2-294-74489-1.00031-0
Renaissance of Aspirin for the Primary and Secondary Prevention of Venous Thromboembolism
Burnett, A., Kelly, L. R., Horner, T., LaBaze, D., Bowman, B. N., & Mahan, C. E. (2013) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-013-0025-3
Efficacy and safety of daily aspirin
Mearns, B. M. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.88
Anticoagulants : stratification du risque en pathologie vasculaire
Cohen, A. A., & Heuzey, J. Y. L. (2014) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(14)71479-x
Y a-t-il des liens entre maladie veineuse thromboembolique et risque artériel ?
Delluc, A., Lacut, K., & Mottier, D. (2014) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(14)71481-8
Maladie thromboembolique : aspirine
Monsuez, J. J. (2012) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/s1261-694x(12)70399-1
Akrawinthawong, K., Park, J., Piknova, B., Sibmooh, N., Fucharoen, S., & Schechter, A. N. (2013) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(13)62067-7
Aspirine et récidive de thrombose veineuse
Monsuez, J. J. (2013) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/s1261-694x(13)70459-0
Laroche, J.-P., Galanaud, J. ‐., Kien, A. K. V., Brisot, D., Böge, G., Pérez‐Martin, A., Schuster, I., Dauzat, M., & Quéré, I. (2013) · Journal des Maladies Vasculaires · doi:10.1016/j.jmv.2012.12.114
Statins are better than fibrates in patients with a previous venous thromboembolism
Squizzato, A., Guasti, L., & Ageno, W. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.09.016
Self-citationÁcido acetilsalicílico en el tratamiento extendido de la enfermedad tromboembólica venosa
Riera‐Mestre, A., & Formiga, F. (2015) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2014.12.001
Aktuelle Therapie und Sekundärprävention der Lungenembolie
Lankeit, M., & Konstantinides, S. (2013) · Der Pneumologe · doi:10.1007/s10405-013-0744-x
Laroche, J.-P., Leizorovicz, A., Meyer, G., & Drouet, L. O. (2013) · Sang thrombose vaisseaux · doi:10.1684/stv.2013.0786
Use of ASA after warfarin for unprovoked VTE.
Allan, G. M., Banh, H. L., & Ference, J. D. (2013) · Europe PMC (PubMed Central)
Chin, E. E. M. T. (2013) · Pancreatic Disorders and Therapy · doi:10.4172/2165-7092.1000126
Andrés Valenzuela, S., & Aizman, A. (2015) · Medwave · doi:10.5867/medwave.2015.03.6118
Duration of anticoagulation: the decision-making process
Thompson, R., & Thachil, J. V. (2015) · British Journal of Hospital Medicine · doi:10.12968/hmed.2015.76.10.c156
Platelets, Endothelium, and Inflammation
Ajzenberg, N., & Huisse, M. (2016) · Encyclopedia of Inflammatory Diseases · doi:10.1007/978-3-0348-0620-6_99-2
Will They Have an Impact? A Closer Look at Recent Nt th T i l Noteworthy Trials
Ellinger, L. K. (2013)
Ward, M., & Ranger, N. S. (2015)
Aktuelle Therapie und Sekundärprävention der Lungenembolie
Lankeit, M., & Konstantinides, S. (2014) · Gefässchirurgie · doi:10.1007/s00772-013-1286-6
Radbel, J. M., Jobanputra, A. M., Singh, J. A., Jagpal, S. K., & Hussain, S. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201509-1821rr
Antikoagulation nach tiefer Venenthrombose
Geier, B., Böhner, H., Balzer, K., Aleksic, M., Nowak, T., Klemp, U., Pillny, M., Kröger, K., & Pourhassan, S. (2013) · Gefässchirurgie · doi:10.1007/s00772-013-1129-5
Postępy w diagnostyce i leczeniu chorych na żylną chorobę zakrzepowo-zatorową
Zawilska, K. (2015) · Hematologia · doi:10.5603/hem.2015.0023
Evaluation of Anti-thrombotic Drugs in View of Recent Mechanism for Venous Thrombus Formation
Hato, T. (2015) · The Japanese Journal of Phlebology · doi:10.7134/phlebol.14-26
Aspirine et maladie thromboembolique veineuse
Lazareth, I. (2013) · Journal des Maladies Vasculaires · doi:10.1016/j.jmv.2012.12.002
Delluc, A., Lacut, K., & Mottier, D. (2012) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.10.363
Aspirin Prevents Recurrent Unprovoked Venous Thromboembolism
Brett, A. S. (2012) · Journal watch · doi:10.1056/jw201205240000001
Venous and arterial thromboembolism
van Schouwenburg, I. M. (2012) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Low-Dose Aspirin in the Cardiovascular System
Casado-Arroyo, R., Lanas, Á., & Brugada, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-33889-7_9
Böhner, H. (2016) · Gefässchirurgie · doi:10.1007/s00772-016-0214-y
Neue Möglichkeiten der oralen Langzeitantikoagulation
Regli, C., & Heizmann, M. (2016) · CardioVasc · doi:10.1007/s15027-016-1029-1
Jiménez-Guiu, X., Romera-Villegas, A., Mestre, F. J. M., Mestre, A. R., & Vila-Coll, R. (2016) · Angiología · doi:10.1016/j.angio.2016.11.001
Pulmoner Embolinin Güncel Tedavisi
Tekin, A. (2016) · Arşiv Kaynak Tarama Dergisi · doi:10.17827/aktd.248425
ディベート1 : 静脈血栓塞栓症予防 : アスピリンは是か非か あくまでピンチヒッターでしかないアスピリン
悟, 藤. (2015) · 心臓 · doi:10.11281/shinzo.47.882
Ondrakova, M., Motovska, Z. J., Waldauf, P., Knot, J., Havlůj, L., Bittner, L., Bartoška, R., Gürlich, R., Krbec, M., Džupa, V., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177519
Current Tendencies in the Prevention of Recurrent Venous Thromboembolism
Ilyukhin, Е. А., & Zolotukhin, I. A. (2017) · Journal of Venous Disorders · doi:10.17116/flebo201711283-90 · Cited by 1
Dürschmied, D., Heinz, J., Siepe, M., & Bode, C. (2015)
Does aspirin have a role in preventing unprovoked recurrent thromboembolism?
Yenny, Y. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.18051/univmed.2013.v32.1-2
Palareti, G. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1366851
Long-term strategies in patients with unprovoked venous thromboembolism
Prandoni, P. (2017) · Phlebologie · doi:10.12687/phleb2372-5-2017
Self-citationKaretová, D., & Bultas, J. (2017) · Klinická farmakologie a farmacie · doi:10.36290/far.2017.014
Role of Antiplatelet Drugs in Deep Vein Thrombosis
Mir, I. A. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i10.34 · Cited by 1
Prevention of Venous Thromboembolism
Sadaghianloo, N., & Dardik, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-65226-9_20
Lurie, F., Abbas, J. T., & Fish, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-65226-9_3
Mój pacjent leczony sulodeksydem — kiedy i dlaczego stosuję?
Gorczyca−Michta, I., & Wożakowska−Kapłon, B. (2017) · Folia Cardiologica · doi:10.5603/fc.2017.0109 · Cited by 1
Thrombose, Lungenembolie und Antikoagulation: Wie und wie lange antikoagulieren?
Geisler, T., & Stimpfle, F. (2018) · Der Klinikarzt · doi:10.1055/a-0575-1650
Anticoagulation in Venous Thromboembolism
Barnes, G. D., & Renner, E. T. (2018) · Springer eBooks · doi:10.1007/978-3-319-73709-6_14
Closing Patent Foramen Ovale (PFO) for Cryptogenic Stroke - Deeper Thoughts
Wong, C. K. (2018) · Cardiovascular Pharmacology Open Access · doi:10.4172/2329-6607.1000e139
EINSTEIN-CHOICE trial – rationale for the extended anticoagulation in secondary prevention
Tamburrini, L. R., Weißer, G., & Espinola–Klein, C. (2018) · VASA · doi:10.1024/0301-1526/a000707
EXTENDED ANTICOAGULANT THERAPYIN PATIENTS, WHO SURVIVED PULMONARY EMBOLISM
Vorobieva, N. M., & Панченко, Е. П. (2018) · Aterotromboz = Atherothrombosis · doi:10.21518/2307-1109-2018-2-36-45
Between a Clot and a Scarred Place
Peter, S., & Lankarani‐Fard, A. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.01.011
Chan, N., & Weitz, J. I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00059-x · Cited by 1
Prevention of recurrent deep-vein thrombosis
Nicolaides, A. K. D. (2019) · Vascular Investigation and Therapy · doi:10.4103/vit.vit_8_19
The effect of Btk inhibition on platelet activation by GPVI and CLEC-2
Nicolson, P. L. R. (2019) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1
Routine Anticoagulation for the Provoked and Unprovoked VTE
Bosch, M. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-25782-8_2
WITHDRAWN: Anticoagulation management strategies in heart transplantation
Rizk, J. G., & Mehra, M. R. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.01.004
RetractedTreatment of Antiphospholipid Syndrome
Sciascia, S., & Khamashta, M. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801917-7.00063-2
Extended therapy and secondary prevention of venous thromboembolic complications
Petrikov, A. S., & Игоревич, П. И. (2020) · I P Pavlov Russian Medical Biological Herald · doi:10.23888/pavlovj2020284548-566
Antithrombotic therapy as a risk factor for nasal bleeding
Извин, А. И., Михайловна, В. И., Rebyatnikova, M. A., Rudzevich, A. V., & Кузнецова, Н. Е. (2021) · Russian otorhinolaryngology · doi:10.18692/1810-4800-2021-1-35-40
MASSIVE PULMONARY EMBOLISM IN OLDER PATIENT: SURVIVAL DESPITE STATISTIC DATA
Makharynska, O. S., Doroshenko, O. V., & Rahul, M. (2017) · DOAJ (DOAJ: Directory of Open Access Journals)
Razavipour, M., Ghaffari, S., Mohebi, M., & Amjadi, S. (2021) · Journal of Research in Orthopedic Science · doi:10.32598/jrosj.8.1.703.2
Thrombosis and myeloma: it is time to get the elephant out of the room
Louzada, M. (2021) · British Journal of Haematology · doi:10.1111/bjh.17507
Role of Follow-Up Duplex Ultrasound Post-Deep Vein Thrombosis
Broering, M. J., & Muck, P. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-49616-6_67-1
Oa, T., & Олеговна, В. О. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-12-8-16
Schmidt, A. F. (2014) · Utrecht University Repository (Utrecht University)
Anderson, M. K., Pickens, R. C., Davis, J. M. K., Baker, E. H., Martinie, J. B., Iannitti, D. A., & Vrochides, D. V. (2021) · International Journal of Hepatobiliary and Pancreatic Diseases · doi:10.5348/100096z04ma2021ra
Bauersachs, R. M., & Krabbe, B. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_208-1
Difficult Choice: When to Prolong Anticoagulation Therapy in Patients with Venous Thromboembolism?
Хрыщанович, В. Я., & Скобелева, Н. Я. (2021) · Кардиология в Беларуси · doi:10.34883/pi.2021.13.5.016
References and Further Reading
Wicker, P., & Dalby, S. (2016) · Wiley eBooks · doi:10.1002/9781119548935.oth7
Clinical Applications of Aspirin
Schrör, K. (2016) · Wiley eBooks · doi:10.1002/9783527685059.ch4
Weg, J. G., Rubenfire, M., & Sofowora, G. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-28328-5_29
Siegel, A. J. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.10.026
Platelets, Endothelium, and Inflammation
Ajzenberg, N., & Huisse, M. (2016) · Compendium of Inflammatory Diseases · doi:10.1007/978-3-7643-8550-7_99
Treatment of antiphospholipid syndrome
Sciascia, S., & Khamashta, M. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814551-7.00065-9
(2016) · VASA · doi:10.1024/0301-1526/a000487
Platelet, Endothelium, and Inflammation
Ajzenberg, N., & Huisse, M. (2013) · Encyclopedia of Inflammatory Diseases · doi:10.1007/978-3-0348-0620-6_99-1
(2012) · British journal of surgery · doi:10.1002/bjs.8961
Metadata
- Authors
- Becattini, C., Agnelli, G., Schenone, A., Eichinger, S., Bucherini, E., Silingardi, M., Bianchi, M., Moia, M., Ageno, W., Vandelli, M. R., Grandone, E., & Prandoni, P.
- Affiliations
- University of Perugia (IT)
- Ente Ospedaliero Ospedali Galliera (IT)
- Medical University of Vienna (AT)
- Ospedale per gli Infermi (IT)
- Santa Maria Nuova Hospital (IT)
- Ospedale Valduce (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- University of Insubria (IT)
- Casa Sollievo della Sofferenza (IT)
- University of Padua (IT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-05-24
- Volume
- 366
- Issue
- 21
- Pages
- 1959-1967
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1975990989
- Cited by
- 620
- References
- 37
- Citations by year
- 2026: 10 · 2025: 27 · 2024: 19 · 2023: 11 · 2022: 23 · 2021: 39 · 2020: 40 · 2019: 34 · 2018: 45 · 2017: 53 · 2016: 52 · 2015: 75 · 2014: 69 · 2013: 90 · 2012: 33
- FWCI
- 57.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Iris (University of Trento) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Funders
- Bristol-Myers Squibb
- Pfizer
- GlaxoSmithKline
- Sanofi
- Bayer HealthCare
- Università degli Studi di Perugia
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Keywords
- aspirin, venous thromboembolism, recurrence prevention, unprovoked venous thromboembolism, major bleeding, secondary prevention, anticoagulation
- MeSH terms
- Aged, Anticoagulants, Aspirin, Double-Blind Method, Female, Follow-Up Studies, Hemorrhage, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Pulmonary Embolism, Vitamin K, Venous Thrombosis, Venous Thromboembolism, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.